Medtronic Neuromodulation recalls Model A710 Intellis Clinician Programmer Application
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Medtronic has discovered an instance in which the Intellis A710 Clinician Programmer Application (CP App) could no longer establish a session with the Implantable Neurostimulator (INS) which resulted in the inability for the clinician to adjust stimulation parameters. In the event of this issue, the patient may receive inadequate or excessive therapy and experience non-optimal pain relief.
- Products
-
- Model A710 Intellis Clinician Programmer Application
- Company
- Medtronic Neuromodulation
- Where it was sold
-
Germany
- Barcodes
00763000520076- Units affected
- 1 tablet
- About this recall
- Model A710 Intellis Clinician Programmer Application, version 2.0.97